Skip to Content

Join the 'Chronic Obstructive Pulmonary Disease' group to help and get support from people like you.

Chronic Obstructive Pulmonary Disease News

Related terms: Bronchitis, Chronic, Bronchitis with Airway Obstruction, Chronic Bronchitis, Chronic Obstructive Airway Disease, Chronic Obstructive Lung Disease, Emphysema, COPD

Health Tip: Understanding COPD

Posted 8 days ago by Drugs.com

-- Chronic obstructive pulmonary disease (COPD) is the third-leading cause of death in the United States, affecting some 16 million Americans and potentially millions more who don't know they have it. According to the National Heart, Blood, and Lung Institute, COPD can make it difficult for people to breathe and harm their quality of life. In COPD, less air flows in and out of the lung's airways due to one or more of these factors: The airways lose their elastic quality. The walls between some of the air sacs are destroyed. The walls of the airways become thick and inflamed. The airways make more mucus than usual and become clogged. Read more

Related support groups: Chronic Obstructive Pulmonary Disease, Chronic Obstructive Pulmonary Disease, Maintenance, Chronic Obstructive Pulmonary Disease, Acute, Bronchiectasis, Respiratory Tract Disease, Alpha-1 Proteinase Inhibitor Deficiency

Rheumatoid Arthritis Linked to Risk of COPD

Posted 18 days ago by Drugs.com

TUESDAY, Oct. 31, 2017 – People with rheumatoid arthritis appear to have a higher risk of the lung condition chronic obstructive pulmonary disease (COPD), researchers report. The study found that people with rheumatoid arthritis were 47 percent more likely to be hospitalized for COPD than those in the general population. Rheumatoid arthritis is an autoimmune disease. That means the body's immune system mistakenly attacks healthy tissue instead of foreign invaders such as bacteria. This causes inflammation, which causes symptoms such as red, swollen and painful joints, according to the Arthritis Foundation. COPD includes diseases such as emphysema and chronic bronchitis. Symptoms include shortness of breath, frequent coughing, a feeling of tightness in the chest and wheezing, the COPD Foundation says. Smoking and secondhand smoke are among the most significant risk factors for COPD. ... Read more

Related support groups: Rheumatoid Arthritis, Chronic Obstructive Pulmonary Disease, Chronic Obstructive Pulmonary Disease, Maintenance, Fluticasone, Qvar, Ribavirin, Budesonide, Flovent, Entocort, Tobramycin, Mometasone, Chronic Obstructive Pulmonary Disease, Acute, Entocort EC, Beclomethasone, Uceris, Pulmicort Flexhaler, Alvesco, Pulmicort Turbuhaler, Asmanex Twisthaler, Copegus

Pollution Tied to 9 Million Deaths Worldwide in 2015

Posted 20 Oct 2017 by Drugs.com

FRIDAY, Oct. 20, 2017 – Pollution led to more than 9 million deaths worldwide in 2015, or 1 in 6 deaths that year, a new report reveals. Air pollution, the worst culprit, was linked to 6.5 million heart- and lung-related deaths, The Lancet Commission on Pollution and Health said. Water pollution was tied to 1.8 million deaths, mostly from gastrointestinal and parasitic infections. And workplace-related pollution and lead pollution also played a role, contributing to 800,000 deaths and 500,000 deaths, respectively. "Pollution is much more than an environmental challenge – it is a profound and pervasive threat that affects many aspects of human health and well-being," said Dr. Philip Landrigan, co-lead of the commission. "It deserves the full attention of international leaders, civil society, health professionals, and people around the world," added Landrigan, a professor at the Icahn ... Read more

Related support groups: Chronic Obstructive Pulmonary Disease, Heart Disease, Ischemic Stroke, Bronchitis, Lung Cancer, Fluticasone, Non-Small Cell Lung Cancer, Qvar, Ribavirin, Budesonide, Flovent, Entocort, Tobramycin, Prevention of Cardiovascular Disease, Mometasone, Entocort EC, Ischemic Stroke - Prophylaxis, Cardiovascular Risk Reduction, Bronchiectasis, Beclomethasone

Switch From Smoking to Vaping Could Save Over 6 Million U.S. Lives

Posted 3 Oct 2017 by Drugs.com

MONDAY, Oct. 2, 2017 – Millions of cigarette smokers could live substantially longer if electronic cigarettes are embraced as a replacement for tobacco during the next decade, a new study contends. As many as 6.6 million cigarette smokers could live a combined 86.7 million more years under policies that encourage them to swap their smokes for e-cigarettes, according to "optimistic" projections from cancer researchers at Georgetown University in Washington, D.C. Even a worst-case scenario involving e-cigarettes would still save lives, the researchers said. Under a "pessimistic" projection, 1.6 million former cigarette smokers would have a combined 20.8 million more years of additional life, the research team found. These numbers show that adopting e-cigarettes as an alternative to smoking could prove the easiest way to cause tobacco use to dwindle in the United States, said lead ... Read more

Related support groups: Cough, Chronic Obstructive Pulmonary Disease, Smoking, Smoking Cessation, Chronic Obstructive Pulmonary Disease, Maintenance, Nicotine, Lung Cancer, Non-Small Cell Lung Cancer, Nicorette, Small Cell Lung Cancer, Nicoderm CQ, Chronic Obstructive Pulmonary Disease, Acute, Nicotrol Inhaler, Commit, Respiratory Tract Disease, Habitrol, Nicorette DS, Nicotrol NS, ProStep, Bronchogenic Carcinoma

Respiratory Disease Death Rates Have Soared

Posted 29 Sep 2017 by Drugs.com

FRIDAY, Sept. 29, 2017 – The number of Americans who die from chronic respiratory diseases has skyrocketed over the past 35 years, led in large part by deaths from COPD, a new report indicates. From 1980 through 2014, more than 4.6 million Americans died from a range of chronic respiratory illnesses, the researchers reported. While the risk was pegged at 41 deaths for every 100,000 people back in 1980, it rose to nearly 53 out of every 100,000 by 2014, representing a nearly 31 percent spike over 35 years. And the dismal news continued in the new report. Eighty-five percent of the deaths – 3.9 million people – were from chronic obstructive pulmonary disease (COPD), which moved up in that period of time to become the third leading cause of death, ahead of stroke, in the United States. Other chronic respiratory illnesses that saw dramatic increases included: particle-inhalation ... Read more

Related support groups: Cough, Chronic Obstructive Pulmonary Disease, Pneumonia, Chronic Obstructive Pulmonary Disease, Maintenance, Fluticasone, Qvar, Ribavirin, Budesonide, Flovent, Entocort, Tobramycin, Entocort EC, Mometasone, Chronic Obstructive Pulmonary Disease, Acute, Bronchiectasis, Beclomethasone, Uceris, Pulmicort Flexhaler, Alvesco, Pulmicort Turbuhaler

Dirty Air Might Harm Your Kidneys

Posted 21 Sep 2017 by Drugs.com

THURSDAY, Sept. 21, 2017 – Air pollution may harm your kidneys, a new study says. "Even levels below the limit set by the [Environmental Protection Agency] were harmful to the kidneys. This suggests that there is no safe level of air pollution," said study leader Dr. Ziyad Al-Aly. Al-Aly is director of clinical epidemiology at the VA Saint Louis Health Care System. He and his colleagues analyzed data from nearly 2.5 million U.S. military veterans who were followed for roughly 8.5 years. They found that as exposure to particulate matter air pollution increased, so did the risk of poorer kidney function, kidney disease and kidney failure. Particle pollution refers to a complex mix of extremely small particles, such as soot, dirt and smoke, and liquid droplets found in the air, according to the U.S. Environmental Protection Agency. It's already known that inhaling these particles can ... Read more

Related support groups: Cough, Chronic Obstructive Pulmonary Disease, Chronic Kidney Disease, Respiratory Tract Disease, Croup, Renal and Genitourinary Disorders

Kids' Colds Linked to Asthma, Lung Problems Later

Posted 19 Sep 2017 by Drugs.com

TUESDAY, Sept. 19, 2017 – Kids who develop respiratory infections like colds or sinusitis may have a higher risk of asthma and reduced lung function later in life, a new study says. Researchers examined data from nearly 155,000 children in Europe. They were followed from birth through ages 4 to 15 years. Those who had an upper respiratory infection – such as a cold, sinusitis, laryngitis and tonsillitis – by age 5 had an increased risk of asthma later in life. Their risk was 1.5 times higher. Young children who had lower respiratory tract infections such as bronchitis, bronchiolitis, pneumonia and general chest infections saw their asthma risk double or quadruple. They were also more likely to later develop reduced lung function, according to the study. "These findings support the hypothesis that early life respiratory tract infections may influence the development of respiratory ... Read more

Related support groups: Cough, Asthma, Chronic Obstructive Pulmonary Disease, Sinusitis, Bronchitis, Pneumonia, Asthma - Maintenance, Nasal Congestion, Cold Symptoms, Dyspnea, Sore Throat, Upper Respiratory Tract Infection, Asthma - Acute, Cough and Nasal Congestion, Bronchiectasis, Sinus Symptoms, Respiratory Tract Disease, Croup, Allergic Asthma, Reversible Airways Disease - Maintenance

FDA Approves Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol) for the Treatment of COPD

Posted 19 Sep 2017 by Drugs.com

London UK – 18 September 2017 – GlaxoSmithKline plc (LSE/NYSE: GSK) and Innoviva, Inc. (NASDAQ: INVA) today announced that the US Food and Drug Administration (FDA) has approved once-daily, single inhaler triple therapy fluticasone furoate/umeclidinium/vilanterol (FF/UMEC/VI), under the brand name Trelegy Ellipta, for the long-term, once-daily, maintenance treatment of patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema, who are on a fixed-dose combination of fluticasone furoate and vilanterol for airflow obstruction and reducing exacerbations in whom additional treatment of airflow obstruction is desired or for patients who are already receiving umeclidinium and a fixed-dose combination of fluticasone furoate and vilanterol. Trelegy Ellipta is not indicated for relief of acute bronchospasm or the treatment of asthma. Trelegy E ... Read more

Related support groups: Chronic Obstructive Pulmonary Disease, Bronchitis, Chronic Obstructive Pulmonary Disease, Maintenance, Fluticasone, Breo Ellipta, Chronic Obstructive Pulmonary Disease, Acute, Anoro Ellipta, Arnuity Ellipta, Umeclidinium, Umeclidinium/vilanterol, Incruse Ellipta, Trelegy Ellipta, Fluticasone/vilanterol, Fluticasone/umeclidinium/vilanterol

Minorities Exposed to Dirtier Air, U.S. Study Finds

Posted 18 Sep 2017 by Drugs.com

MONDAY, Sept. 18, 2017 – Nonwhite Americans are surrounded by more air pollution from traffic than whites are, a new study finds. While exposure to nitrogen dioxide (NO2) fell among all Americans between 2000 and 2010, there was only a slight narrowing in differences between levels of exposure to the pollutant between nonwhites and whites. "The finding that shocks us is that when it comes to how much NO2 a person breathes, it's still race that matters," said senior study author Julian Marshall. He is professor of civil and environmental engineering at the University of Washington in Seattle. "At any income level – low to medium to high – there's a persistent gap by race, which is completely indefensible. It says a lot about how segregated neighborhoods still are and how things are segregated," he explained in a university news release. The estimated average annual NO2 exposure fell ... Read more

Related support groups: Cough, Asthma, Chronic Obstructive Pulmonary Disease, Poisoning, Bronchiectasis, Respiratory Tract Disease, Toxic Reactions Incl Drug and Substance Abuse, Croup, Reversible Airways Disease, Bronchospastic Disease

Statins May Help People With COPD Live Longer

Posted 8 Sep 2017 by Drugs.com

FRIDAY, Sept. 8, 2017 – Drugs known as statins may have benefits beyond lowering "bad" LDL cholesterol levels. A new study suggests people with chronic lung disease who take these drugs may extend their survival. The study from Canada included nearly 40,000 people with chronic obstructive pulmonary disease (COPD). One in five patients was taking a statin, and those individuals had a 21 percent lower risk of dying from any cause, and a 45 percent reduced risk of dying from lung-related issues, the researchers found. This study comes on the heels of a separate large-scale investigation that found no link between statin use and the number of COPD exacerbations people experienced. "While evidence from a recently completed [randomized controlled trial] suggested that statin use is of little benefit to COPD patients, this population-based analysis showed that statin use reduced all-cause ... Read more

Related support groups: Chronic Obstructive Pulmonary Disease, High Cholesterol, Lipitor, Simvastatin, Atorvastatin, Crestor, Pravastatin, Chronic Obstructive Pulmonary Disease, Maintenance, Lovastatin, Zocor, Rosuvastatin, Red Yeast Rice, Pravachol, Chronic Obstructive Pulmonary Disease, Acute, Livalo, Alpha-1 Proteinase Inhibitor Deficiency, Lescol XL, Lescol, Mevacor, Pitavastatin

Long-Acting Inhaler May Help in Early Stage COPD, Too

Posted 6 Sep 2017 by Drugs.com

WEDNESDAY, Sept. 6, 2017 – The inhaler medication Spiriva (tiotropium bromide) may help slow the progression of COPD if given in the early stages of the disease, a new study suggests. Researchers found that the drug helped patients preserve more lung function over two years. It also cut down on symptom flare-ups and boosted patients' quality of life, on average. All of the study patients were in the early stages of chronic obstructive pulmonary disease, or COPD – a group of serious lung conditions that include emphysema and chronic bronchitis. Experts said the study, funded by Spiriva maker Boehringer Ingelheim, could help change the way early COPD is managed. Until now, nothing has been shown to slow the progression of early COPD – other than smoking cessation, said Dr. Louis DePalo, a lung disease specialist who wasn't involved in the study. "Quitting smoking is the one thing ... Read more

Related support groups: Chronic Obstructive Pulmonary Disease, Smoking, Smoking Cessation, Spiriva, Chronic Obstructive Pulmonary Disease, Maintenance, Chronic Obstructive Pulmonary Disease, Acute, Spiriva HandiHaler, Tiotropium, Stiolto Respimat, Alpha-1 Proteinase Inhibitor Deficiency, Spiriva Respimat, Olodaterol/tiotropium

Smoking Linked to Frailty in Seniors

Posted 29 Aug 2017 by Drugs.com

TUESDAY, Aug. 29, 2017 – Seniors who smoke may be more likely to become frail, a new British study suggests. Researchers tracked more than 2,500 people 60 and older in England and found that current smoking boosted that risk by about 60 percent. The scientists determined that the participants were frail if they had at least three of five conditions: unintentional weight loss, self-reported exhaustion, weakness, slow walking speed, and low physical activity. Frail people are at higher risk of problems such as falls, broken bones and hospitalization. Researchers have also linked frailty to poor quality of life and dementia. Interestingly, the researchers found that former smokers didn't face a higher risk of frailty, and it didn't matter if they'd quit within the past 10 years or earlier. In fact, their risks of frailty were about the same as those who had never smoked. The research team ... Read more

Related support groups: Chronic Obstructive Pulmonary Disease, Smoking, Smoking Cessation, Chronic Obstructive Pulmonary Disease, Maintenance, Nicotine, Nicorette, Nicoderm CQ, Chronic Obstructive Pulmonary Disease, Acute, Nicotrol Inhaler, Commit, Habitrol, Nicorette DS, Nicotrol NS, ProStep, Nicotrol TD, Nicorelief

FDA: Serious Problems at Florida Stem Cell Clinic

Posted 29 Aug 2017 by Drugs.com

A Florida stem cell clinic has been cited by the U.S. Food and Drug Administration for what the agency describes as serious problems that could pose health risks to patients. The agency said Monday that it has cited US Stem Cell Clinic, of Sunrise, for marketing stem cell products without FDA approval and for "significant deviations from current good manufacturing practice requirements," including some that could affect the "sterility of their products, putting patients at risk." "Stem cell clinics that mislead vulnerable patients into believing they are being given safe, effective treatments that are in full compliance with the law are dangerously exploiting consumers and putting their health at risk," FDA Commissioner Dr. Scott Gottlieb said in a news release. The FDA said it recently inspected US Stem Cell Clinic and found that it was processing fat tissue into stem cells derived ... Read more

Related support groups: Chronic Obstructive Pulmonary Disease, Heart Disease, Parkinson's Disease, Chronic Obstructive Pulmonary Disease, Maintenance, Amyotrophic Lateral Sclerosis, Chronic Obstructive Pulmonary Disease, Acute, Diagnosis and Investigation, Parkinsonism, Parkinsonian Tremor

Nearly 4 Million Worldwide Die Each Year From Asthma, COPD

Posted 17 Aug 2017 by Drugs.com

WEDNESDAY, Aug. 16, 2017 – Two major chronic lung diseases – asthma and COPD – kill nearly 4 million people worldwide annually, a new report finds. The study calculates that 3.2 million people died in 2015 from COPD (chronic obstructive pulmonary disease) – a group of lung conditions that includes emphysema and chronic bronchitis, often tied to smoking. Asthma caused another 400,000 deaths, the report found. While asthma is more common, COPD is much more deadly. And while both conditions can be treated, many people remain undiagnosed or misdiagnosed. In addition, in many countries, treatment – if it exists at all – may be at insufficient levels, the research team added. "Although much of the burden [from these illnesses] is either preventable or treatable with affordable interventions, these diseases have received less attention than other prominent non-communicable diseases like ... Read more

Related support groups: Cough, Asthma, Chronic Obstructive Pulmonary Disease, Bronchitis, Asthma - Maintenance, Chronic Obstructive Pulmonary Disease, Maintenance, Dyspnea, Fluticasone, Qvar, Ribavirin, Budesonide, Asthma - Acute, Flovent, Entocort, Bronchial, Tobramycin, Cough and Nasal Congestion, Chronic Obstructive Pulmonary Disease, Acute, Entocort EC, Mometasone

Climate Change May Trigger 60,000 More Premature Deaths by 2030

Posted 31 Jul 2017 by Drugs.com

MONDAY, July 31, 2017 – If nothing is done to address climate change, tens of thousands more early deaths may occur worldwide from exposure to air pollution in the coming decades, a new study contends. Increases in air pollution caused by rising temperatures will trigger an additional 60,000 premature deaths each year around the globe by 2030, and as many as 260,000 more premature deaths annually by 2100, according to the results of several different climate models. More people will die from diseases like heart attack, stroke, lung cancer and chronic obstructive pulmonary disease (COPD), which are exacerbated by exposure to smog-laden air, said study co-author Jason West. He's an associate professor of environmental sciences and engineering with the University of North Carolina's Gillings School of Global Public Health. The projected deaths occur "under a scenario where no big policies ... Read more

Related support groups: Cough, Asthma, Chronic Obstructive Pulmonary Disease, Bronchitis, Chronic Obstructive Pulmonary Disease, Maintenance, Dyspnea, Dehydration, Cough and Nasal Congestion, Chronic Obstructive Pulmonary Disease, Acute, Bronchiectasis, Respiratory Tract Disease, Heat Stress, Reversible Airways Disease

Page 1 2 3 ... Next

Ask a Question

Further Information

Related Condition Support Groups

Chronic Obstructive Pulmonary Disease, Maintenance, Chronic Obstructive Pulmonary Disease, Acute, Alpha-1 Proteinase Inhibitor Deficiency, Respiratory Tract Disease

Related Drug Support Groups

prednisone, Symbicort, montelukast, Breo Ellipta, Daliresp, Xopenex, Bronchial, Anoro Ellipta, Stiolto Respimat, view more... Tudorza Pressair, Rayos, umeclidinium, Xopenex HFA, Trelegy Ellipta, Incruse Ellipta, Striverdi Respimat, guaifenesin / theophylline, levalbuterol, roflumilast, Bevespi Aerosphere, umeclidinium / vilanterol, Broncodur, Xopenex Concentrate, Theophyll-GG, Ed-Bron G, Theo G, Equibron G, Solu-Phyllin GG, Broncomar GG, Theocon, Quibron-300, budesonide / formoterol, Theolate, Lufyllin, aclidinium, fluticasone / vilanterol, olodaterol, olodaterol / tiotropium, formoterol / glycopyrrolate, fluticasone / umeclidinium / vilanterol, Dylix, Dilor, Quibron, Uni Bronchial, Elixophyllin-GG, Theomar GG, Neothylline, Lufyllin-400, dyphylline, Asbron G, Slo-Phyllin GG, Glyceryl T, Dilor-400